Login
Subscribe
Lack of Diversity in Genetic Datasets is Risky for Treating Disease
Lack of Diversity in Genetic Datasets is Risky for Treating Disease
Certain populations have been historically underrepresented in genome sequencing studies, but the NIH, private clinics, and 23andMe and other companies are trying to fix that.
Certain populations have been historically underrepresented in genome sequencing studies, but the NIH, private clinics, and 23andMe and other companies are trying to fix that.
cystic fibrosis, genetics & genomics
New Lung Cell Identified
Abby Olena, PhD | Aug 1, 2018 | 4 min read
The cell type was discovered via single-cell RNA sequencing of thousands of cells in mouse and human airways and may play a role in cystic fibrosis.
CF Gene Therapy Shows Promise
Jef Akst | Jul 6, 2015 | 1 min read
The results of a Phase 2 trial suggest that delivering normal copies of the gene that causes cystic fibrosis may slow lung decline.
FDA Approves NGS Tests
Tracy Vence | Nov 21, 2013 | 1 min read
The agency has cleared marketing of four next-generation sequencing devices from Illumina.
The Road Less Traveled
Megan Scudellari | Nov 1, 2012 | 9 min read
First, Aravinda Chakravarti drew a map of how scientists might unravel the genetics of complex disease. Then he blazed the trail.